The International journal of eating disorders · 2025
Frequency and Predictors of Shape/Weight Concerns and Objective Binge Eating in Avoidant/Restrictive Food Intake Disorder (ARFID).
СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kambanis P Evelyna, Palmer Lilian P, Jhe Grace, McPherson Iman, Graver Haley, Dalton Abigail G, Ji Chunni, Asanza Elisa, Shabazian Lauren, Dunford Ashley, Breithaupt Lauren, Freizinger Melissa, Eddy Kamryn T, Misra Madhusmita, Micali Nadia, Holsen Laura, Lawson Elizabeth A, Becker Kendra R, Thomas Jennifer J
Аннотация
OBJECTIVE: DSM-5 prohibits the diagnosis of avoidant/restrictive food intake disorder (ARFID) in the context of clinically significant shape/weight concerns. However, emerging data suggest that ARFID and shape/weight concerns may co-occur, and DSM-5-TR now permits comorbid binge-eating disorder alongside ARFID. We compared shape/weight concerns in adults with ARFID to healthy controls (HCs) and nonclinical norms; assessed the frequency of clinical-level shape/weight concerns and past-month objective binge episodes (OBE); and identified ARFID characteristics linked to elevated shape/weight concerns and OBEs. We hypothesized that individuals with ARFID would exhibit lower shape/weight concerns than HCs and nonclinical norms, that none would exhibit clinical-level shape/weight concerns, and that higher weight would predict greater shape/weight concerns. Our examination of OBEs was exploratory.
METHOD: Participants with ARFID (N = 83) and HCs (N = 41) completed the Eating Disorder Examination-Questionnaire (EDE-Q).
RESULTS: Adults with ARFID scored significantly higher than HCs but significantly lower than nonclinical norms on shape/weight concerns. Two percent exhibited clinical-level shape/weight concerns, and 15% reported past-month OBEs. Higher weight uniquely predicted shape/weight concerns.
DISCUSSION: Shape/weight concerns are lower in ARFID than in the general population, and a small proportion of adults with ARFID-particularly those at higher weights-may experience clinical-level shape/weight concerns and OBEs.
METHOD: Participants with ARFID (N = 83) and HCs (N = 41) completed the Eating Disorder Examination-Questionnaire (EDE-Q).
RESULTS: Adults with ARFID scored significantly higher than HCs but significantly lower than nonclinical norms on shape/weight concerns. Two percent exhibited clinical-level shape/weight concerns, and 15% reported past-month OBEs. Higher weight uniquely predicted shape/weight concerns.
DISCUSSION: Shape/weight concerns are lower in ARFID than in the general population, and a small proportion of adults with ARFID-particularly those at higher weights-may experience clinical-level shape/weight concerns and OBEs.